1. Home
  2. YHC vs WINT Comparison

YHC vs WINT Comparison

Compare YHC & WINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YHC
  • WINT
  • Stock Information
  • Founded
  • YHC 2021
  • WINT 1992
  • Country
  • YHC United States
  • WINT United States
  • Employees
  • YHC N/A
  • WINT N/A
  • Industry
  • YHC Beverages (Production/Distribution)
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • YHC Consumer Staples
  • WINT Health Care
  • Exchange
  • YHC Nasdaq
  • WINT Nasdaq
  • Market Cap
  • YHC 1.9M
  • WINT 2.2M
  • IPO Year
  • YHC N/A
  • WINT 1995
  • Fundamental
  • Price
  • YHC $0.95
  • WINT $0.14
  • Analyst Decision
  • YHC
  • WINT Hold
  • Analyst Count
  • YHC 0
  • WINT 1
  • Target Price
  • YHC N/A
  • WINT $350.00
  • AVG Volume (30 Days)
  • YHC 7.1M
  • WINT 5.2M
  • Earning Date
  • YHC 08-12-2025
  • WINT 08-26-2025
  • Dividend Yield
  • YHC N/A
  • WINT N/A
  • EPS Growth
  • YHC N/A
  • WINT N/A
  • EPS
  • YHC N/A
  • WINT N/A
  • Revenue
  • YHC $2,390,517.00
  • WINT N/A
  • Revenue This Year
  • YHC $69.97
  • WINT N/A
  • Revenue Next Year
  • YHC $403.29
  • WINT N/A
  • P/E Ratio
  • YHC N/A
  • WINT N/A
  • Revenue Growth
  • YHC 31.49
  • WINT N/A
  • 52 Week Low
  • YHC $0.86
  • WINT $0.10
  • 52 Week High
  • YHC $98.00
  • WINT $662.00
  • Technical
  • Relative Strength Index (RSI)
  • YHC 43.37
  • WINT 24.01
  • Support Level
  • YHC $0.86
  • WINT $0.45
  • Resistance Level
  • YHC $0.96
  • WINT $0.51
  • Average True Range (ATR)
  • YHC 0.14
  • WINT 0.08
  • MACD
  • YHC 0.02
  • WINT -0.05
  • Stochastic Oscillator
  • YHC 9.49
  • WINT 8.93

About YHC LQR House Inc. Common Stock

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

Share on Social Networks: